148 related articles for article (PubMed ID: 10200866)
1. Fatal Stevens-Johnson syndrome in an AIDS patient treated with sulfadiazine.
Carrión-Carrión C; Morales-Suárez-Varela MM; Llopis-González A
Ann Pharmacother; 1999 Mar; 33(3):379-80. PubMed ID: 10200866
[No Abstract] [Full Text] [Related]
2. [Drug-induced Stevens-Johnson syndrome in a patient with AIDS].
Schlienger RG; Haefeli WE; Bircher A; Leib SL; Lüscher TF
Schweiz Rundsch Med Prax; 1993 Aug; 82(33):888-92. PubMed ID: 8372290
[TBL] [Abstract][Full Text] [Related]
3. [Acute renal failure caused by sulfadiazine crystalluria in AIDS. An historical resurgent iatrogenic complication].
De Jaureguiberry JP; Reboul P; Vey N; Jaubert D
Ann Med Interne (Paris); 1992; 143(3):218-9. PubMed ID: 1524357
[No Abstract] [Full Text] [Related]
4. [Crystalluria induced by sulfadiazine in an AIDS patient].
Bressollette L; Carlhant D; Bellein V; Morand C; Mottier D; Riche C
Therapie; 1994; 49(2):154-5. PubMed ID: 7817352
[No Abstract] [Full Text] [Related]
5. Randomized controlled trial of pyrimethamine plus sulfadiazine versus trimethoprim plus sulfamethoxazole for treatment of toxoplasmic encephalitis in AIDS patients.
Kongsaengdao S; Samintarapanya K; Oranratnachai K; Prapakarn W; Apichartpiyakul C
J Int Assoc Physicians AIDS Care (Chic); 2008; 7(1):11-6. PubMed ID: 17517949
[TBL] [Abstract][Full Text] [Related]
6. [Acute kidney failure due to sulfadiazine in the treatment of cerebral toxoplasmosis].
Corbella X; Mascaró J; Santín M; Carratalà J
Rev Clin Esp; 1992 Apr; 190(6):330-1. PubMed ID: 1598436
[No Abstract] [Full Text] [Related]
7. Sulfadiazine-induced crystalluria and renal failure in a patient with AIDS.
Dong BJ; Rodriguez RA; Goldschmidt RH
J Am Board Fam Pract; 1999; 12(3):243-8. PubMed ID: 10395422
[No Abstract] [Full Text] [Related]
8. [Renal failure caused by sulfadiazine in a HIV patient with toxoplasmic encephalitis].
Solano Remírez M; Oliván Ballabriga AS; da Costa Rodríguez GM; Alvarez Frías MT; González Arencibia C
An Med Interna; 2005 Aug; 22(8):395-6. PubMed ID: 16351495
[No Abstract] [Full Text] [Related]
9. [Efficacy of atovaquone in resistant toxoplasmosis in AIDS].
Lafeuillade A; Pellegrino P; Poggi C; Profizi N; Quilichini R; Chouette I; Navarreté MS
Presse Med; 1993 Oct; 22(33):1708. PubMed ID: 8278330
[No Abstract] [Full Text] [Related]
10. Encephalopathy and psychoses associated with sulfadiazine in two patients with AIDS and CNS toxoplasmosis.
Reboli AC; Mandler HD
Clin Infect Dis; 1992 Sep; 15(3):556-7. PubMed ID: 1520811
[No Abstract] [Full Text] [Related]
11. [HIV infection and Lyell syndrome: a wake-up call concerning anti-inflammatory agents].
de Luis DA; Fortun J; Pintado V; Aller de la Fuente R
Enferm Infecc Microbiol Clin; 1997 Apr; 15(4):231-2. PubMed ID: 9312293
[No Abstract] [Full Text] [Related]
12. Adverse cutaneous reactions to pyrimethamine/sulfadiazine and pyrimethamine/clindamycin in patients with AIDS and toxoplasmic encephalitis.
Caumes E; Bocquet H; Guermonprez G; Rogeaux O; Bricaire F; Katlama C; Gentilini M
Clin Infect Dis; 1995 Sep; 21(3):656-8. PubMed ID: 8527561
[TBL] [Abstract][Full Text] [Related]
13. [Kidney failure caused by sulphadiazine in patients with toxoplasma encephalitis].
Fernández-Ayala M; Fariñas MC; Nan D; González-Macías J
An Med Interna; 2000 Nov; 17(11):616-7. PubMed ID: 11322040
[No Abstract] [Full Text] [Related]
14. [Cerebral toxoplasmosis in a patient with Waldenström's macroglobulinemia].
Olmos Soto S; Reus Bañuls S; Mora Castera E; Villarubia Lor MB
Enferm Infecc Microbiol Clin; 2014 Oct; 32(8):549-50. PubMed ID: 24913993
[No Abstract] [Full Text] [Related]
15. [Acute encephalopathy caused by sulfadiazine and trimethoprim-sulfamethoxazole in a patient with AIDS].
Arjol AM; Sánchez C; Dalmau D
Enferm Infecc Microbiol Clin; 1998 May; 16(5):250-1. PubMed ID: 9666594
[No Abstract] [Full Text] [Related]
16. Atovaquone as long-term suppressive therapy for toxoplasmic encephalitis in patients with AIDS and multiple drug intolerance. Atovaquone Expanded Access Group.
Katlama C; Mouthon B; Gourdon D; Lapierre D; Rousseau F
AIDS; 1996 Sep; 10(10):1107-12. PubMed ID: 8874627
[TBL] [Abstract][Full Text] [Related]
17. [Diabetes insipidus as a manifestation of cerebral toxoplasmosis in an AIDS patient].
Sánchez JF; Olmedo MC; Pascua FJ; Casado I
Rev Neurol; 2000 May 16-31; 30(10):939-40. PubMed ID: 10919191
[TBL] [Abstract][Full Text] [Related]
18. Sulphadiazine-induced renal stones in a 63-year-old HIV-infected man treated for toxoplasmosis.
McGettigan BD; Hew M; Phillips E; McLean-Tooke A
BMJ Case Rep; 2012 Sep; 2012():. PubMed ID: 23001098
[TBL] [Abstract][Full Text] [Related]
19. Sulfadiazine/N4-acetylsulfadiazine crystalluria in a patient with the acquired immune deficiency syndrome (AIDS).
Potter JL; Kofron WG
Clin Chim Acta; 1994 Oct; 230(2):221-4. PubMed ID: 7834873
[No Abstract] [Full Text] [Related]
20. Obstructive nephropathy due to sulfa crystals in two HIV seropositive patients treated with sulfadiazine.
Colebunders R; Depraetere K; De Droogh E; Kamper A; Corthout B; Bottiau E
JBR-BTR; 1999 Aug; 82(4):153-4. PubMed ID: 10555419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
